MSK Commack. — Commack, New York

MSK Commack. is a clinical research site located in Commack, New York, United States 11725.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

MSK Commack. has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Commack.?

MSK Commack. has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Commack. conducted?

MSK Commack. has 5 clinical trials on record, with 3 currently active. Their work covers Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral.

Is MSK Commack. accredited by Crixeo Health?

MSK Commack. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSK Commack.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.